stars 1 stars 2 stars 3

Effimune S.A.S. is a biotechnology company conducting research and development of innovative drug candidates for transplantation and immune-mediated diseases. The company specializes in the development of first-in-class biological drug candidates targeting cells of the immune system to restore the balance between effector and regulatory mechanisms. Three product candidates are currently in development, one of them in collaboration with our partners Janssen Biotech.

Effimune Questions

The Effimune annual revenue was $5 million in 2026.

Marc Moguilewsky is the VP Business Development of Effimune.

1 people are employed at Effimune.

Effimune is based in Nantes, Pays de la Loire.

The NAICS codes for Effimune are [541713, 541, 5417, 54171, 54].

The SIC codes for Effimune are [87, 873].

Top Effimune Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users